Need for transfusions falls with erythropoietin before surgery

05/9/2013 | PhysiciansBriefing.com

Patients who received human recombinant erythropoietin in the days before heart surgery needed less transfused blood, according to findings presented at a thoracic surgery meeting. The randomized prospective study looked at about 600 cardiac surgery patients. Erythropoietin is a viable but underutilized tool for patient blood management, said Dr. Luca Weltert of the European Hospital in Rome.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA